» Articles » PMID: 9690508

Excision of Mismatched Nucleotides from DNA: a Potential Mechanism for Enhancing DNA Replication Fidelity by the Wild-type P53 Protein

Overview
Journal Oncogene
Date 1998 Aug 5
PMID 9690508
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor suppressor p53 plays a critical role in the regulation of the cell cycle and the maintenance of genetic stability. The 3'-->5' exonuclease activity of p53 has recently been recognized as a novel biochemical function of this molecule, but the biological significance of this activity remains elusive. Using an in vitro DNA replication assay with purified human DNA polymerases, p53 protein, and defined DNA primer/templates, we demonstrated that the wild-type (wt) p53 protein, but not the mutant p53 protein, specifically enhanced the DNA replication fidelity of polymerase (pol) alpha, an enzyme that lacks 3'-->5' exonuclease activity. The misincorporation of non-complementary deoxynucleotides into DNA by pol alpha was substantially decreased by p53. In contrast, wt p53 showed no significant effect on replication fidelity or the rates of DNA synthesis by human pol epsilon or the bacterial enzyme pol I. Inhibition of 3'-->5' exonuclease activity by guanosine monophosphate (GMP) abolished the ability of p53 to enhance the replication fidelity of pol alpha. Quantitative analyses revealed that the 3'-->5' exonuclease activity of p53 effectively removed mismatched nucleotides from DNA in preference over matched nucleotides. Furthermore, study in intact cells revealed that the wt p53 protein was co-localized with DNA synthesis activity in S phase cells. These results suggest a possibility that the 3'-->5' exonuclease of the wt p53 protein might provide the proof-reading function for DNA pol alpha. The preferential excision of mismatched nucleotides from the replicating DNA strand appears to be a potential biochemical mechanism by which p53 enhances DNA replication fidelity and thereby helps to maintain genomic integrity.

Citing Articles

The Role of Tumor Suppressor p53 Protein in HIV-Host Cell Interactions.

Bakhanashvili M Cells. 2024; 13(18.

PMID: 39329696 PMC: 11429533. DOI: 10.3390/cells13181512.


Metal-Based Anticancer Complexes and p53: How Much Do We Know?.

Alfadul S, Matnurov E, Varakutin A, Babak M Cancers (Basel). 2023; 15(10).

PMID: 37345171 PMC: 10216058. DOI: 10.3390/cancers15102834.


Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.

Ellison V, Annor G, Freedman C, Xiao G, Lundine D, Freulich E Oncotarget. 2021; 12(12):1128-1146.

PMID: 34136083 PMC: 8202772. DOI: 10.18632/oncotarget.27975.


DNA polymerase δ proofreads errors made by DNA polymerase ε.

Bulock C, Xing X, Shcherbakova P Proc Natl Acad Sci U S A. 2020; 117(11):6035-6041.

PMID: 32123096 PMC: 7084062. DOI: 10.1073/pnas.1917624117.


How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.

Ho T, Tan B, Lane D Int J Mol Sci. 2019; 21(1).

PMID: 31861395 PMC: 6982169. DOI: 10.3390/ijms21010013.